Monthly Round-Up of What to Read on Pharma Law and Policy
Bill of Health
MARCH 25, 2022
A New Way to Contain Unaffordable Medication Costs – Exercising the Government’s Existing Rights. Medicaid Expenditures and Estimated Rebates on Line Extension Drugs, 2010-2018. Association Between Payments by Pharmaceutical Manufacturers and Prescribing Behavior in Rheumatology. Mayo Clin Proc. PMID: 35120693.
Let's personalize your content